GLP-1 agonists reduce appetite, modulate satiety circuits, alter hepatic lipid handling, improve endothelial function, attenuate inflammatory tone, influence microglial behavior, and appear to exert downstream neuroprotective effects, yet the field cannot convincingly articulate how these effects relate to one another, which are primary versus secondary, or which are merely correlative epiphenomena arising from broader systemic shifts
On a syringe marked every unit, it falls at the midpoint between 12 and 13
They also have customer support available to answer any questions you may have
Localized redness, itching, swelling, or mild discomfort at injection sites typically occur as mild to moderate reactions that resolve within days